Literature DB >> 28340227

Transplant as a competing risk in the analysis of dialysis patients.

Nan van Geloven1, Saskia le Cessie1,2, Friedo W Dekker2, Hein Putter1.   

Abstract

Time-to-event analyses are frequently used in nephrology research, for instance, when recording time to death or time to peritonitis in dialysis patients. Many papers have pointed out the important issue of competing events (or competing risks) in such analyses. For example, when studying one particular cause of death it can be noted that patients also die from other causes. Such competing events preclude the event of interest from occurring and thereby complicate the statistical analysis. The Kaplan-Meier approach to calculating the cumulative probability of the event of interest yields invalid results in the presence of competing risks, thus the alternative cumulative incidence competing risk (CICR) approach has become the standard. However, when kidney transplant is the competing event that prevents observing the outcome of interest, CICR may not always be the matter of interest. We discuss situations where both the Kaplan-Meier and the CICR approach are not suitable for the purpose and point out alternative analysis methods for such situations. We also look at the suitability and interpretation of different estimators for relative risks. In the presence of transplant as a competing risk, one should very clearly state the research question and use an analysis method that targets this question.
© The Author 2017. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.

Entities:  

Keywords:  competing risks; dialysis; prognosis; survival analysis; transplantation

Mesh:

Year:  2017        PMID: 28340227     DOI: 10.1093/ndt/gfx012

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  7 in total

Review 1.  Statistical Considerations for Analyses of Time-To-Event Endpoints in Oncology Clinical Trials: Illustrations with CAR-T Immunotherapy Studies.

Authors:  Yimei Li; Wei-Ting Hwang; Shannon L Maude; David T Teachey; Noelle V Frey; Regina M Myers; Allison Barz Leahy; Hongyan Liu; David L Porter; Stephan A Grupp; Pamela A Shaw
Journal:  Clin Cancer Res       Date:  2022-09-15       Impact factor: 13.801

2.  A Brief Introduction to Competing Risks in the Context of Kidney Disease Epidemiology.

Authors:  Nicholas S Roetker; David T Gilbertson; Eric D Weinhandl
Journal:  Kidney360       Date:  2022-02-17

3.  Timing of dialysis initiation to reduce mortality and cardiovascular events in advanced chronic kidney disease: nationwide cohort study.

Authors:  Edouard L Fu; Marie Evans; Juan-Jesus Carrero; Hein Putter; Catherine M Clase; Fergus J Caskey; Maciej Szymczak; Claudia Torino; Nicholas C Chesnaye; Kitty J Jager; Christoph Wanner; Friedo W Dekker; Merel van Diepen
Journal:  BMJ       Date:  2021-11-29

4.  Intercurrent events in clinical research: the norm, not the exception.

Authors:  L Paloma Rojas-Saunero; Cecilia María Patino; Juliana Carvalho Ferreira
Journal:  J Bras Pneumol       Date:  2022-09-05       Impact factor: 2.800

Review 5.  Considerations of Competing Risks Analysis in Cardio-Oncology Studies: JACC: CardioOncology State-of-the-Art Review.

Authors:  Yimei Li; Lova Sun; Danielle S Burstein; Kelly D Getz
Journal:  JACC CardioOncol       Date:  2022-09-20

6.  Association of Statin and Its Lipophilicity With Cardiovascular Events in Patients Receiving Chronic Dialysis.

Authors:  Shih-Wei Wang; Lung-Chih Li; Chien-Hao Su; Yao-Hsu Yang; Tsuen-Wei Hsu; Chien-Ning Hsu
Journal:  Clin Pharmacol Ther       Date:  2019-12-18       Impact factor: 6.875

7.  The Novel Bone Alkaline Phosphatase Isoform B1x Is Associated with Improved 5-Year Survival in Chronic Kidney Disease.

Authors:  Mathias Haarhaus; Anders Fernström; Abdul Rashid Qureshi; Per Magnusson
Journal:  Nutrients       Date:  2021-12-09       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.